Acute colonic pseudo-obstruction syndrome in patients with severe COVID-19 in Buenos Aires, Argentina
Travel Medicine and Infectious Disease · 2023
DOI: 10.1016/j.tmaid.2023.102604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Travel Medicine and Infectious Disease, 2023. Verfasst von Luciana María Gulisano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hospital de Infecciosas F.J. Muñiz, Department of Infectious Diseases, Buenos Aires, Argentina. Electronic address: lucianagulisano@gmail.com. Hauptthemen laut MEDLINE: Colonic Pseudo-Obstruction, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Several gastrointestinal complications have been reported in patients with COVID-19, including motility disorders, such as acute colonic pseudo-obstruction (ACPO). This affection is characterized by colonic distention in the absence of mechanical obstruction. ACPO in the context of severe COVID-19 may be related to neurotropism and direct damage of SARS-CoV-2 in enterocytes. METHOD: We conducted a retrospective study of patients who were hospitalized for critical COVID-19 and developed ACPO between March 2020 and September 2021. The diagnostic criteria to define ACPO was the presence of 2 or more of the following: abdominal distension, abdominal pain, and changes in the bowel movements, associated with distension of the colon in computed tomography. Data of sex, age, past medical history, treatment, and outcomes were collected. RESULTS: Five patients were detected. All required admission to the Intensive Care Unit. The ACPO syndrome developed with a mean of 33.8 days from the onset of symptoms. The mean duration of the ACPO syndrome was 24.6 days. The treatment included colonic decompression with placement of rectal and nasogastric tubes, endoscopy decompression in two patients, bowel rest, fluid, and electrolytes replacement. One patient died. The remaining resolved the gastrointestinal symptoms without surgery. CONCLUSIONS: ACPO is an infrequent complication in patients with COVID-19. It occurs especially in patients with critical condition, who require prolonged stays in intensive care and multiple pharmacological treatments. It is important to recognize its presence early and thus establish an appropriate treatment, since the risk of complications is high.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital de Infecciosas F.J. Muñiz, Department of Infectious Diseases, Buenos Aires, Argentina. Electronic address: lucianagulisano@gmail.com.
- Hospital de Infecciosas F.J. Muñiz, Department of Infectious Diseases, Buenos Aires, Argentina.
- Hospital de Infecciosas F.J. Muñiz, Unit of Surgery, Buenos Aires, Argentina.
- Hospital de Infecciosas F.J. Muñiz, Intensive Care Unit, Buenos Aires, Argentina.
Zitieren
APA
Gulisano, L. M., Ianiro Swiderski, J. J., Fernández, M. L., Giuliano, J. F., Fernández Stepa, A. L., Dominguez, C., Nahoum, N., Jourdan, J., Trombetta, L. Á., & García, J. L. (2023). Acute colonic pseudo-obstruction syndrome in patients with severe COVID-19 in Buenos Aires, Argentina. Travel Medicine and Infectious Disease. https://doi.org/10.1016/j.tmaid.2023.102604
Vancouver
Gulisano LM, Ianiro Swiderski JJ, Fernández ML, Giuliano JF, Fernández Stepa AL, Dominguez C, et al. Acute colonic pseudo-obstruction syndrome in patients with severe COVID-19 in Buenos Aires, Argentina. Travel Medicine and Infectious Disease. 2023. doi:10.1016/j.tmaid.2023.102604
BibTeX
@article{Gulisano2023,
author = {Gulisano, Luciana María and Ianiro Swiderski, Joaquín José and Fernández, Marisa Liliana and Giuliano, Juan Franco and Fernández Stepa, Ana Laura and Dominguez, Cecilia and Nahoum, Nicolás and Jourdan, Johana and Trombetta, Luis Ángel and García, Julián Luis},
title = {Acute colonic pseudo-obstruction syndrome in patients with severe COVID-19 in Buenos Aires, Argentina},
journal = {Travel Medicine and Infectious Disease},
year = {2023},
doi = {10.1016/j.tmaid.2023.102604}
}
EUVIMED